Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
University of California, Davis
Bayer
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Jazz Pharmaceuticals
Daiichi Sankyo
Brigham and Women's Hospital
Mayo Clinic
Tempus AI
GlaxoSmithKline
University of California, Irvine
Elevation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Exelixis
National Institutes of Health Clinical Center (CC)
Sun Yat-sen University
Universitair Ziekenhuis Brussel
pharmaand GmbH
AstraZeneca
OncoNano Medicine, Inc.
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Main Line Health
NRG Oncology
Mary Crowley Medical Research Center
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Novartis
University of Oxford
City of Hope Medical Center
Takeda
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
The University of Texas Health Science Center at San Antonio
Fred Hutchinson Cancer Center
Cancer Research UK
Memorial Sloan Kettering Cancer Center
St. Luke's-Roosevelt Hospital Center
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)